WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized
Dr. Shaikh Abdullah bin Ahmed Al Khalifa, Undersecretary of the Ministry of Foreign Affairs for Political Affairs, held a meeting in Madrid with Josep Borrell, High Representative of the European Union for Foreign Affairs and Security Policy. The meeting took
Dr. Shaikh Abdullah bin Ahmed Al Khalifa, Undersecretary of the Ministry of Foreign Affairs for Political Affairs, met with Diego Martínez Belío, Spain’s State Secretary for Foreign and Global Affairs, in Madrid. The meeting took place on the sidelines of
Dr. Shaikh Abdullah bin Ahmed Al Khalifa, Undersecretary of the Ministry of Foreign Affairs for Political Affairs, took part in a meeting chaired by Spain’s Prime Minister, Pedro Sánchez, in Madrid. The meeting, attended by foreign ministers and senior officials,